1. |
Mirza S, Clay RD, Koslow MA, et al. COPD Guidelines: A Review of the 2018 GOLD Report. Mayo Clin Proc, 2018, 93(10): 1488-1502.
|
2. |
Rehman AU, Hassali M, Muhammad SA, et al. The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature. Eur J Health Econ, 2020, 21(2): 181-194.
|
3. |
Koch M, Butt T, Guo W, et al. Characteristics and health burden of the undiagnosed population at risk of chronic obstructive pulmonary disease in China. BMC Public Health, 2019, 19(1): 1727.
|
4. |
Iheanacho I, Zhang S, King D, et al. Economic burden of chronic obstructive pulmonary disease (copd): a systematic literature review. Int J Chron Obstruct Pulmon Dis, 2020, 15: 439-460.
|
5. |
Ko FW, Chan KP, Hui DS, et al. Acute exacerbation of COPD. Respirology, 2016, 21(7): 1152-1165.
|
6. |
Chen YW, Leung JM, Sin DD. A systematic review of diagnostic biomarkers of COPD exacerbation. PLoS One, 2016, 11(7): e158843.
|
7. |
Xiong W, Xu M, Zhao Y, et al. Can we predict the prognosis of COPD with a routine blood test?. Int J Chron Obstruct Pulmon Dis, 2017, 12: 615-625.
|
8. |
杨凤. 降钙素原、C 反应蛋白联合检测在慢性阻塞性肺疾病急性加重期中的临床意义. 2020, 23(S1): 173-174.
|
9. |
Gunay E, Sarinc US, Akar O, et al. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation, 2014, 37(2): 374-380.
|
10. |
Vestbo J, Rennard S. Chronic obstructive pulmonary disease biomarker(s) for disease activity needed--urgently. Am J Respir Crit Care Med, 2010, 182(7): 863-864.
|
11. |
Thomsen M, Ingebrigtsen TS, Marott JL, et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA, 2013, 309(22): 2353-2361.
|
12. |
Pizzini A, Lunger F, Sahanic A, et al. Diagnostic and prognostic value of inflammatory parameters including neopterin in the setting of pneumonia, COPD, and acute exacerbations. COPD, 2017, 14(3): 298-303.
|
13. |
Huerta A, Crisafulli E, Menéndez R, et al. Pneumonic and nonpneumonic exacerbations of COPD. Chest, 2013, 144(4): 1134-1142.
|
14. |
Lin TL, Chen WW, Ding ZR, et al. Correlations between serum amyloid A, C-reactive protein and clinical indices of patients with acutely exacerbated chronic obstructive pulmonary disease. J Clin Lab Anal, 2019, 33(4): e22831.
|
15. |
Singh S, Verma SK, Kumar S, et al. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers. Immunol Lett, 2018, 196: 1-10.
|
16. |
Acarturk T E, Karakurt Z, Aksoy E, et al. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker. Int J Chron Obstruct Pulmon Dis, 2017, 12: 3361-3370.
|
17. |
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Arch Bronconeumol, 2017, 53(3): 128-149.
|
18. |
Shaw JG, Vaughan A, Dent AG, et al. Biomarkers of progression of chronic obstructive pulmonary disease (COPD). J Thorac Dis, 2014, 6(11): 1532-1547.
|
19. |
Cataudella E, Giraffa CM, Di Marca S, et al. Neutrophil-to-lymphocyte ratio: an emerging marker predicting prognosis in elderly adults with community-acquired pneumonia. J Am Geriatr Soc, 2017, 65(8): 1796-1801.
|
20. |
Strassheim D, Dempsey EC, Gerasimovskaya E, et al. Role of inflammatory cell subtypes in heart failure. J Immunol Res, 2019, 2019: 2164017.
|
21. |
Arbel Y, Shacham Y, Ziv-Baran T, et al. Higher neutrophil/lymphocyte ratio is related to lower ejection fraction and higher long-term all-cause mortality in ST-elevation myocardial infarction patients. Can J Cardiol, 2014, 30(10): 1177-1182.
|
22. |
Lee H, Um SJ, Kim YS, et al. Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease. PLoS One, 2016, 11(6): e156511.
|
23. |
Ernst P, Saad N, Suissa S. Inhaled corticosteroids in COPD: the clinical evidence. Eur Respir J, 2015, 45(2): 525-537.
|
24. |
王红梅, 刘耘充, 郑丹蕾, 等. 血嗜酸性粒细胞作为生物标志物在慢性阻塞性肺疾病中的研究进展. 中华全科医学, 2020, 18(5): 815-820.
|
25. |
Chis AF, Pop CM. Correlations between neutrophil to lymphocyte ratio, blood eosinophils and clinical characteristics in chronic obstructive pulmonary disease. Med Pharm Rep, 2020, 93(2): 169-174.
|
26. |
Rahimirad S, Ghaffary MR, Rahimirad MH, et al. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease. Tuberk Toraks, 2017, 65(1): 25-31.
|
27. |
Dentali F, Nigro O, Squizzato A, et al. Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature. Int J Cardiol, 2018, 266: 31-37.
|
28. |
Liu S, Zheng H, Zhu X, et al. Neutrophil-to-lymphocyte ratio is associated with diabetic peripheral neuropathy in type 2 diabetes patients. Diabetes Res Clin Pract, 2017, 130: 90-97.
|